These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7690213)
1. Specific and effective T-cell recognition of cells transfected with a truncated human mucin cDNA. Magarian-Blander J; Domenech N; Finn OJ Ann N Y Acad Sci; 1993 Aug; 690():231-43. PubMed ID: 7690213 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Jerome KR; Barnd DL; Bendt KM; Boyer CM; Taylor-Papadimitriou J; McKenzie IF; Bast RC; Finn OJ Cancer Res; 1991 Jun; 51(11):2908-16. PubMed ID: 1709586 [TBL] [Abstract][Full Text] [Related]
3. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. Jerome KR; Domenech N; Finn OJ J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. Ioannides CG; Fisk B; Jerome KR; Irimura T; Wharton JT; Finn OJ J Immunol; 1993 Oct; 151(7):3693-703. PubMed ID: 7690810 [TBL] [Abstract][Full Text] [Related]
5. Recombinant vaccinia mucin vector: in vitro analysis of expression of tumor-associated epitopes for antibody and human cytotoxic T-cell recognition. Bu D; Domenech N; Lewis J; Taylor-Papadimitriou J; Finn OJ J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):127-35. PubMed ID: 7506575 [TBL] [Abstract][Full Text] [Related]
6. Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA. Jerome KR; Bu D; Finn OJ Cancer Res; 1992 Nov; 52(21):5985-90. PubMed ID: 1382849 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of MUC1 on transfected cell lines influences its recognition by MUC1 specific T cells. Magarian-Blander J; Hughey RP; Kinlough C; Poland PA; Finn OJ Glycoconj J; 1996 Oct; 13(5):749-56. PubMed ID: 8910002 [TBL] [Abstract][Full Text] [Related]
8. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Barnd DL; Lan MS; Metzgar RS; Finn OJ Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7159-63. PubMed ID: 2674949 [TBL] [Abstract][Full Text] [Related]
9. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. Takahashi T; Makiguchi Y; Hinoda Y; Kakiuchi H; Nakagawa N; Imai K; Yachi A J Immunol; 1994 Sep; 153(5):2102-9. PubMed ID: 8051415 [TBL] [Abstract][Full Text] [Related]
10. Lack of evidence for MHC-unrestricted (atypical) recognition of mucin by mucinous pancreatic tumour-reactive T-cells. Selvan RS; Pappas TN; Ward FE Br J Cancer; 2000 Feb; 82(3):691-701. PubMed ID: 10682684 [TBL] [Abstract][Full Text] [Related]
11. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity. Irimura T; Denda K; Iida Si; Takeuchi H; Kato K J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin. Noto H; Takahashi T; Makiguchi Y; Hayashi T; Hinoda Y; Imai K Int Immunol; 1997 May; 9(5):791-8. PubMed ID: 9184925 [TBL] [Abstract][Full Text] [Related]
13. [New mucin core protein genes and their clinical application]. Imai K Hokkaido Igaku Zasshi; 1996 Mar; 71(2):139-43. PubMed ID: 8641670 [TBL] [Abstract][Full Text] [Related]
14. Functional and molecular analysis of T cell receptors used by pancreatic- and breast tumor- (mucin-) specific cytotoxic T cells. Kirii Y; Magarian-Blander J; Alter MD; Kotera Y; Finn OJ J Immunother; 1998 May; 21(3):188-97. PubMed ID: 9610910 [TBL] [Abstract][Full Text] [Related]
15. Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells. Pecher G; Finn OJ Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1699-704. PubMed ID: 8643693 [TBL] [Abstract][Full Text] [Related]
16. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1. Magarian-Blander J; Ciborowski P; Hsia S; Watkins SC; Finn OJ J Immunol; 1998 Apr; 160(7):3111-20. PubMed ID: 9531265 [TBL] [Abstract][Full Text] [Related]
17. Making the most of mucin: a novel target for tumor immunotherapy. Barratt-Boyes SM Cancer Immunol Immunother; 1996 Nov; 43(3):142-51. PubMed ID: 9001567 [TBL] [Abstract][Full Text] [Related]
18. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585 [TBL] [Abstract][Full Text] [Related]